ICH harmonised guideline integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2)

International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use.

A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. Ethical and scientific quality standards for designing, conducting, recording and reporting trials that involve participation of human subjects to ensure that the rights, safety and wellbeing of the trial subjects are protected. Ensure the credibility of clinical trial data.

TABLE OF CONTENTS

INTRODUCTION TO ICH GCP 

1. GLOSSARY 

2. THE PRINCIPLES OF ICH GCP 

3. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) 

4. INVESTIGATOR 

5. SPONSOR 

6. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S) 

7. INVESTIGATOR’S BROCHURE 

8. ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 

 

© European Medicines Agency, 2018

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Upcoming Clinical Research Events

All events

Upcoming Clinical Trials

Clinical Research Jobs

All jobs

Sponsors and Collaborators

Medical Conditions

Drug Interventions